Cardiovascular Systems, Inc. is a medical technology company, which is engaged in treating patients suffering from peripheral and coronary artery diseases.

According to the law firm press release, the lawsuit alleges that throughout the Class, Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Cardiovascular Systems distributed illegal kickbacks to health care providers; (2) Cardiovascular Systems engaged in the off-label promotion of its medical devices; and (3) Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices. As a result of the foregoing, the Company’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

The first filed case was voluntarily dismissed on April 26, 2016. A later filed action in the District of Minnesota continues under 16-CV-00568.

Lead Plaintiff filed an amended Complaint on June 27, 2017. Defendants filed a Motion to Dismiss the amended Complaint on August 11. On January 10, 2018, the Court issued an Order granting Defendants' Motion to Dismiss, dismissing the case with prejudice.